Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Reasearch ArticleClinical Studies
Open Access

The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer

DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM and STEVEN E. SCHILD
Anticancer Research June 2022, 42 (6) 3035-3039; DOI: https://doi.org/10.21873/anticanres.15789
DIRK RADES
1Departments of Radiation Oncology, and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dirk.rades{at}uksh.de
BRITTA WARWAS
1Departments of Radiation Oncology, and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLORIAN CREMERS
1Departments of Radiation Oncology, and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARSTEN GERULL
1Departments of Radiation Oncology, and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RALPH PRIES
2Departments of Oto-Rhino-Laryngology and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANKE LEICHTLE
2Departments of Oto-Rhino-Laryngology and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARL L. BRUCHHAGE
2Departments of Oto-Rhino-Laryngology and Head and Neck Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAMER G. HAKIM
3Oral and Maxillofacial Surgery, University of Lübeck, Lübeck, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEVEN E. SCHILD
4Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    The grade ≥3 late xerostomia rates related to the patient scores.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 6
June 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer
DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD
Anticancer Research Jun 2022, 42 (6) 3035-3039; DOI: 10.21873/anticanres.15789

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer
DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD
Anticancer Research Jun 2022, 42 (6) 3035-3039; DOI: 10.21873/anticanres.15789
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Development of Distress During a Radiotherapy Course for Head-and-neck Cancer
  • Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy Alone
  • Google Scholar

More in this TOC Section

  • Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
  • Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy
  • Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
Show more Clinical Studies

Keywords

  • head-and-neck cancer
  • radiotherapy
  • late xerostomia
  • prognostic tool
  • treatment planning
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire